Investigation into State-level Changes in Use of Long-acting Reversible Contraception Shows Differences Persist

The growing use of long-acting reversible contraception (LARC) in the federal Title X family planning programs suggests more low-income women who want to avoid pregnancy are able to access one of the most effective forms of contraception. However, increases in LARC use by Title X family planning clients aren’t distributed evenly across states, a team from East Tennessee State University found.

Trump Administration Contraceptive Rule Creates Problems for Both Women’s Health and Scientific Integrity

The Jacobs Institute of Women's Health joined colleagues at the National Partnership for Women & Families and the Union of Concerned Scientists in submitting comments on a Trump Administration rule allowing employers that offer health insurance to stop covering contraception without cost-sharing.

Susan Wood Receives Barbara Seamen Award for Activism in Women’s Health

Associate Professor and Director of the Jacobs Institute of Women’s Health Susan Wood was honored with the Barbara Seamen Award for Activism in Women’s Health by the the National Women’s Health Network. The celebration took place on June 12 from 6-8 pm at the Whittemore House (1526 New Hampshire Avenue, NW, Washington, DC 20036).

Among Adults Experiencing Homelessness, Risks Differ for Men, Women, and Transgender Individuals

New study shows 56% of transgender participants had been violently attacked while homeless

Melissa Goldstein Invited to Attend Susan G. Komen Big Data for Breast Cancer West Coast Conference

Associate Professor Melissa Goldstein was invited to attend Big Data for Breast Cancer West Coast Conference (BD4BC\WC), a convening of experts around big data for breast cancer that was held Feb. 23-Feb. 24, 2017 in Menlo Park, California. The meeting was hosted by the Susan G. Komen organization, with support from the Robertson Foundation.